Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China · Delayed Price · Currency is CNY 74.50
+10.40 (16.22%)
At close: Feb 27, 2026
SHE:301075 Revenue
Tibet Duo Rui Pharmaceutical had revenue of 30.43M CNY in the quarter ending September 30, 2025, a decrease of -39.32%. This brings the company's revenue in the last twelve months to 177.11M, down -38.62% year-over-year. In the year 2024, Tibet Duo Rui Pharmaceutical had annual revenue of 240.63M, down -28.02%.
Revenue (ttm)
177.11M
Revenue Growth
-38.62%
P/S Ratio
33.21
Revenue / Employee
356.35K
Employees
497
Market Cap
5.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 240.63M | -93.67M | -28.02% |
| Dec 31, 2023 | 334.30M | -66.75M | -16.64% |
| Jan 1, 2023 | 401.05M | -128.57M | -24.28% |
| Jan 1, 2022 | 529.62M | 39.45M | 8.05% |
| Dec 31, 2020 | 490.16M | 40.74M | 9.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition